XM n’offre pas ses services aux résidents des États-Unis d’Amérique.

U.S. BioNTech, Honeywell International, Klaviyo



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>U.S. RESEARCH ROUNDUP-BioNTech, Honeywell International, Klaviyo</title></head><body>

June 12 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biontech, Honeywell International and Klaviyo, on Wednesday.


HIGHLIGHTS

* BioNTech SE BNTX.O: JP Morgan raises target price to $94 from $90

* Honeywell International Inc HON.O: HSBC raises target price to $235 from $200

* Klaviyo Inc KVYO.N: Barclays raises to overweight from equal weight

* NetApp Inc NTAP.O: Susquehanna raises target price to $155 from $138

* Welltower Inc WELL.N: Scotiabank raises target price to $110 from $108


Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.


* Academy Sports and Outdoors Inc ASO.O: Evercore ISI cuts target price to $60 from $70

* Academy Sports and Outdoors Inc ASO.O: Guggenheim cuts target price to $65 from $75

* Academy Sports and Outdoors Inc ASO.O: Jefferies cuts target price to $68 from $81

* Academy Sports and Outdoors Inc ASO.O: Morgan Stanley cuts target price to $60 from $65

* Academy Sports and Outdoors Inc ASO.O: TD Cowen cuts target price to $58 from $82

* Academy Sports and Outdoors Inc ASO.O: Telsey Advisory Group cuts PT to $65 from $75

* Academy Sports and Outdoors Inc ASO.O: Truist Securities cuts PT to $60 from $73

* Academy Sports and Outdoors Inc ASO.O: UBS cuts target price to $58 from $81

* Academy Sports and Outdoors Inc ASO.O: UBS cuts to neutral from buy

* Academy Sports and Outdoors Inc ASO.O: Wedbush cuts target price to $65 from $80

* Academy Sports and Outdoors Inc ASO.O: Wells Fargo cuts target price to $55 from $80

* Academy Sports and Outdoors Inc ASO.O: Wells Fargo cuts to equal weight from overweight

* Addus Homecare Corp ADUS.O: BofA Global Research resumes coverage with buy rating

* Addus Homecare Corp ADUS.O: BofA Global Research resumes coverage with price objective $135

* Agco Corporation AGCO.N: Oppenheimer cuts target price to $133 from $145

* Agree Realty Corp ADC.N: KeyBanc initiates coverage with overweight rating and $68 PT

* Apellis Pharmaceuticals Inc APLS.O: JP Morgan cuts target price to $72 from $79

* Aramark ARMK.N: Oppenheimer raises target price to $39 from $36

* Autodesk Inc ADSK.O: Barclays cuts target price to $275 from $310

* Autodesk Inc ADSK.O: BMO cuts target price to $254 from $293

* Autodesk Inc ADSK.O: Citigroup raises target price to $295 from $286

* Autodesk Inc ADSK.O: Deutsche Bank cuts target price to $245 from $265

* Autodesk Inc ADSK.O: JP Morgan cuts target price to $245 from $260

* Avidity Biosciences Inc RNA.O: Chardan Capital Markets raises PT to $45 from $33

* BioNTech SE BNTX.O: JP Morgan raises target price to $94 from $90

* Bloom Energy Corp BE.N: RBC raises target price to $15 from $14

* Broadstone Net Lease Inc BNL.N: KeyBanc initiates coverage with sector weight rating

* Brown-Forman Corp BFb.N: Truist Securities cuts target price to $50 from $80

* Caseys General Stores Inc CASY.O: RBC raises target price to $361 from $322

* Celsius Holdings Inc CELH.O: Morgan Stanley cuts target price to $68 from $75

* Celsius Holdings Inc CELH.O: Stifel cuts target price to $85 from $95

* Celsius Holdings Inc CELH.O: Wedbush cuts target price to $83 from $85

* Clearway Energy Inc CWENa.N: CIBC raises target price to $32 from $31

* Comerica Inc CMA.N: RBC cuts target price to $58 from $62

* Comerica Inc CMA.N: Truist Securities cuts target price to $55 from $60

* Darden Restaurants Inc DRI.N: Morgan Stanley cuts target price to $175 from $180

* Darden Restaurants Inc. DRI.N: Morgan Stanley cuts target price to $175.00 from $180.00

* Darling Ingredients Inc DAR.N: Citigroup cuts target price to $48 from $50

* Darling Ingredients Inc DAR.N: Citigroup raises to buy from neutral

* DXC Technology Co DXC.N: Susquehanna raises target price to $19 from $15

* Element Solutions Inc ESI.N: BMO raises target price to $30 from $28

* Element Solutions Inc ESI.N: Mizuho raises target price to $29 from $28

* Energy Fuels Inc. UUUU.A: H.C. Wainwright raises target price to $10.75 from $10

* Expeditors International of Washington Inc EXPD.N: BofA Global Research raises price objective to $131 from $126

* First Solar Inc FSLR.O: Baird raises target price to $344 from $246

* First Solar Inc FSLR.O: Oppenheimer raises target price to $325 from $271

* Fiserv Inc FI.N: Wells Fargo initiates coverage with overweight rating; PT $180

* Fortinet Inc FTNT.O: BofA Global Research removes stock from its US 1 list

* Funko Inc FNKO.O: D.A. Davidson raises target price to $12 from $10.5

* Gamestop Corp GME.N: Wedbush cuts target price to $11 from $13.5

* Global Payments Inc GPN.N: Wells Fargo initiates with equal weight rating; PT $100

* Haemonetics Corp HAE.N: Needham raises to buy from hold

* Harley-Davidson Inc HOG.N: Citigroup cuts target price to $34 from $36

* Honeywell International Inc HON.O: HSBC raises target price to $235 from $200

* Intra-Cellular Therapies Inc ITCI.O: JP Morgan raises target price to $78 from $75

* Kinder Morgan Inc KMI.N: UBS raises target price to $24 from $22

* Klaviyo Inc KVYO.N: Barclays raises target price to $29 from $25

* Klaviyo Inc KVYO.N: Barclays raises to overweight from equal weight

* Mama'S Creations Inc MAMA.O: Craig-Hallum raises target price to $9 from $8

* Manitowoc Company Inc MTW.N: UBS cuts target price to $14.5 from $18

* McCormick & Company Inc MKC.N: Citigroup raises target price to $69 from $68

* McCormick & Company Inc MKC.N: Citigroup raises to neutral from sell

* MKS Instruments Inc MKSI.O: TD Cowen raises target price to $160 from $150

* Moderna Inc MRNA.O: JP Morgan raises target price to $96 from $85

* Moderna Inc MRNA.O: Oppenheimer raises target price to $179 from $163

* Monster Beverage Corp MNST.O: Roth MKM cuts target price to $56 from $59

* NCR Voyix Corp VYX.N: Stifel initiates coverage With Buy rating; target price $16

* NetApp Inc NTAP.O: JP Morgan raises target price to $130 from $125

* NetApp Inc NTAP.O: Morgan Stanley raises target price to $127 from $106

* NetApp Inc NTAP.O: Stifel raises target price to $138 from $130

* NetApp Inc NTAP.O: Susquehanna raises target price to $155 from $138

* NetApp Inc NTAP.O: TD Cowen raises target price to $145 from $135

* Neurocrine Biosciences Inc NBIX.O: JP Morgan raises target price to $169 from $158

* Nextera Energy Inc NEE.N: BMO raises target price to $79 from $78

* Nextera Energy Inc NEE.N: Guggenheim raises target price to $83 from $82

* Nextera Energy Inc NEE.N: Mizuho cuts to neutral from buy

* Nextera Energy Inc NEE.N: RBC raises target price to $84 from $74

* Nextera Energy Partners LP NEP.N: CIBC raises target price to $35 from $34

* Nextera Energy Partners LP NEP.N: Mizuho cuts to neutral from buy

* Old Dominion Freight Line, Inc. ODFL.O: Barclays cuts target price to $195 from $205

* Oracle Corp ORCL.N: Barclays raises target price to $160 from $147

* Oracle Corp ORCL.N: Barclays raises target price to $160 from $147

* Oracle Corp ORCL.N: Bernstein raises target price to $171 from $159

* Oracle Corp ORCL.N: BofA Global Research raises price objective to $155 from $144

* Oracle Corp ORCL.N: Evercore ISI raises target price to $160 from $145

* Oracle Corp ORCL.N: Guggenheim raises target price to $175 from $150

* Oracle Corp ORCL.N: JP Morgan raises target price to $110 from $105

* Oracle Corp ORCL.N: Morgan Stanley raises target price to $125 from $115

* Oracle Corp ORCL.N: Stifel raises target price to $135 from $120

* Oracle Corp ORCL.N: TD Cowen raises target price to $165 from $145

* Oracle Corp ORCL.N: UBS raises target price to $160 from $150

* Oracle Corporation ORCL.N: Morgan Stanley raises target price to $125.00 from $115.00

* Pagerduty, Inc. PD.N: Craig-Hallum raises target price to $30 from $21

* Pagerduty, Inc. PD.N: Craig-Hallum raises to buy from hold

* Pepsico Inc. PEP.O: Barclays cuts target price to $180 from $185

* Petmed Express Inc PETS.O: Morgan Stanley cuts target price to $3.5 from $6.5

* Procore Technologies Inc PCOR.N: TD Cowen initiates coverage with buy rating; PT $85

* Protagonist Therapeutics Inc PTGX.O: JP Morgan raises target price to $39 from $37

* Realty Income Corp O.N: KeyBanc initiates coverage with sector weight rating

* Regeneron Pharmaceuticals Inc REGN.O: RBC raises target price to $1,229 from $1,200

* Rockwell Automation Inc ROK.N: Daiwa Capital Markets cuts target price to $295 from $305

* Rubrik, Inc. RBRK.N: Barclays raises target price to $42 from $41

* Salesforce Inc CRM.N: BofA Global Research removes stock from its US 1 list

* Sherwin-Williams Co SHW.N: BMO cuts target price to $360 from $377

* Skechers USA Inc SKX.N: Wells Fargo initiates coverage with overweight rating

* Skechers USA Inc SKX.N: Wells Fargo initiates coverage with price target $83

* Southwest Airlines Co LUV.N: TD Cowen raises target price to $26 from $25

* Springworks Therapeutics Inc SWTX.O: JP Morgan cuts target price to $64 from $77

* Teladoc Health Inc TDOC.N: Deutsche Bank cuts target price to $15 from $16

* Ultragenyx Pharmaceutical Inc RARE.O: JP Morgan raises target price to $94 from $92

* United Therapeutics Corp UTHR.O: Wells Fargo raises target price to $350 from $325

* Ventas Inc VTR.N: Scotiabank raises target price to $52 from $51

* Vornado Realty Trust VNO.N: BMO cuts target price to $29 from $31

* Welltower Inc WELL.N: Scotiabank raises target price to $110 from $108

* Zai Lab Ltd ZLAB.O: JP Morgan raises target price to $43 from $38

* Ziprecruiter Inc ZIP.N: UBS cuts target price to $11 from $13


(Compiled by Bengaluru Newsroom)

</body></html>

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques